Connection

MING HU to Biological Transport

This is a "connection" page, showing publications MING HU has written about Biological Transport.
Connection Strength

1.227
  1. A new strategy to rapidly evaluate kinetics of glucuronide efflux by breast cancer resistance protein (BCRP/ABCG2). Pharm Res. 2012 Nov; 29(11):3199-208.
    View in: PubMed
    Score: 0.093
  2. UDP-glucuronosyltransferase (UGT) 1A9-overexpressing HeLa cells is an appropriate tool to delineate the kinetic interplay between breast cancer resistance protein (BRCP) and UGT and to rapidly identify the glucuronide substrates of BCRP. Drug Metab Dispos. 2012 Feb; 40(2):336-45.
    View in: PubMed
    Score: 0.089
  3. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. Drug Metab Dispos. 2011 Oct; 39(10):1866-72.
    View in: PubMed
    Score: 0.087
  4. Highly variable contents of phenolics in St. John's Wort products affect their transport in the human intestinal Caco-2 cell model: pharmaceutical and biopharmaceutical rationale for product standardization. J Agric Food Chem. 2010 Jun 09; 58(11):6650-9.
    View in: PubMed
    Score: 0.081
  5. Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides. Mol Pharm. 2009 Nov-Dec; 6(6):1703-15.
    View in: PubMed
    Score: 0.077
  6. Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. J Altern Complement Med. 2008 Apr; 14(3):287-97.
    View in: PubMed
    Score: 0.069
  7. Commentary: bioavailability of flavonoids and polyphenols: call to arms. Mol Pharm. 2007 Nov-Dec; 4(6):803-6.
    View in: PubMed
    Score: 0.067
  8. Mechanisms responsible for poor oral bioavailability of paeoniflorin: Role of intestinal disposition and interactions with sinomenine. Pharm Res. 2006 Dec; 23(12):2768-80.
    View in: PubMed
    Score: 0.063
  9. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother Pharmacol. 2005 Feb; 55(2):159-69.
    View in: PubMed
    Score: 0.054
  10. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates. J Pharmacol Exp Ther. 2004 Sep; 310(3):1103-13.
    View in: PubMed
    Score: 0.053
  11. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model. Mol Pharm. 2004 May-Jun; 1(3):194-200.
    View in: PubMed
    Score: 0.053
  12. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model. J Pharmacol Exp Ther. 2004 Jul; 310(1):376-85.
    View in: PubMed
    Score: 0.052
  13. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of apigenin in the Caco-2 cell culture model. J Pharmacol Exp Ther. 2003 Oct; 307(1):314-21.
    View in: PubMed
    Score: 0.050
  14. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos. 2002 Apr; 30(4):370-7.
    View in: PubMed
    Score: 0.046
  15. Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase. Pharm Res. 1999 Sep; 16(9):1352-9.
    View in: PubMed
    Score: 0.038
  16. Determination of absorption characteristics of AG337, a novel thymidylate synthase inhibitor, using a perfused rat intestinal model. J Pharm Sci. 1998 Jul; 87(7):886-90.
    View in: PubMed
    Score: 0.035
  17. Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4. Pharm Res. 1996 Nov; 13(11):1635-41.
    View in: PubMed
    Score: 0.031
  18. Peptide transporter function and prolidase activities in Caco-2 cells: a lack of coordinated expression. J Drug Target. 1995; 3(4):291-300.
    View in: PubMed
    Score: 0.028
  19. Comparison of the transport characteristics of D- and L-methionine in a human intestinal epithelial model (Caco-2) and in a perfused rat intestinal model. Pharm Res. 1994 Dec; 11(12):1771-6.
    View in: PubMed
    Score: 0.028
  20. Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2). Pharm Res. 1994 Oct; 11(10):1405-13.
    View in: PubMed
    Score: 0.027
  21. Mechanisms and kinetics of uptake and efflux of L-methionine in an intestinal epithelial model (Caco-2). J Nutr. 1994 Oct; 124(10):1907-16.
    View in: PubMed
    Score: 0.027
  22. Pharmacokinetics and renal disposition of polymyxin B in an animal model. Antimicrob Agents Chemother. 2012 Nov; 56(11):5724-7.
    View in: PubMed
    Score: 0.023
  23. Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): uptake and efflux of phenylalanine. Biochim Biophys Acta. 1992 Jun 29; 1135(3):233-44.
    View in: PubMed
    Score: 0.023
  24. Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm Res. 1990 Dec; 7(12):1313-9.
    View in: PubMed
    Score: 0.021
  25. Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression. Eur J Pharm Sci. 2000 Nov; 12(1):63-8.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.